{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:10:10Z","timestamp":1756361410588,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1136\/dtb.2018.000045","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T12:35:51Z","timestamp":1549024551000},"page":"18-18","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["COPD: how many asthmatics does it take to make an impact?"],"prefix":"10.1136","volume":"57","author":[{"given":"Jo","family":"Congleton","sequence":"first","affiliation":[{"name":"Brighton and Sussex University Hospitals NHS Trust, East Sussex, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"2025082722514159000_57.2.18.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075221","article-title":"Overtreatment of COPD with inhaled corticosteroids - implications for safety and costs: cross-sectional observational study","volume":"8","author":"White","year":"2013","journal-title":"PLoS One"},{"key":"2025082722514159000_57.2.18.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407154"},{"key":"2025082722514159000_57.2.18.3","unstructured":"Global Initiative for Chronic Obstructive Lung Disease, 2018. GOLD reports [online]. Available: https:\/\/goldcopd.org\/ [Accessed 12 December 2018]."},{"key":"2025082722514159000_57.2.18.4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Resp Med"},{"key":"2025082722514159000_57.2.18.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01370-2015"},{"key":"2025082722514159000_57.2.18.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"issue":"supp 62","key":"2025082722514159000_57.2.18.7","article-title":"Late breaking abstract - blood eosinophil counts and treatment response in COPD: analyses of IMPACT","volume":"52","author":"Pascoe","year":"2018","journal-title":"Eur Respir J"},{"key":"2025082722514159000_57.2.18.8","unstructured":"National Institute for Health and Care Excellence, 2018. Chronic obstructive pulmonary disease in over 16s: diagnosis and management [online]. Available: https:\/\/www.nice.org.uk\/guidance\/ng115 [Accessed 12 December 2018]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2018.000045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:51:48Z","timestamp":1756360308000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2018.000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,1]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/dtb.2018.000045"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2018.000045","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}